Isolation of Tumor-Infiltrating Lymphocytes from Dissociated Tumor Cells
May 4th 2021Tumor-infiltrating lymphocytes may hold the key to treating solid tumors with cell therapies, and BioIVT’s DTC product line is a great source for TILs. In this white paper, you’ll read about defining what TILs are, their potential therapeutic applications, the characterization of BioIVT’s current donor pool by TIL content and the frequency of TILs by tumor tissue type.
Red Blood Cell Contaminants: Upstream Mitigation for Downstream Success
April 27th 2021When isolating peripheral blood mononuclear cells (PBMCs) from whole blood, red blood cell (RBC) contamination can have a significant impact on your downstream results. In this white paper, learn the sources of RBC contamination, the downstream impact of RBC contamination and mitigation strategies that will improve your results.
Helium Leak Detection Technology for Today’s High-Risk Pharmaceuticals
April 23rd 2021This article will discuss pharmaceutical package testing specifically Helium leak detection technology and how it solves cold supply chain challenges of today’s high-risk pharmaceutical products. This article also addresses the importance of phase appropriate leak testing from manufacturing through product lifecycle.
Single-use Technology for Frozen Bulk Drug Storage
April 21st 2021Explore single-use bag system technologies for freeze/thaw applications in bulk drug substance (BDS) manufacturing. Transitioning to SUT can be an efficient, cost-effective option for biopharmaceutical manufacturers to hit performance targets.
Downstream Biologics Characterization: Stability, Formulations and Aggregation Studies using Octet®
April 12th 2021Aggregates can affect the efficacy and safety of biologics. Few biophysical tools offer a combination of structural and functional assessment. Octet® systems can detect aggregates while monitoring functional activity at the formulation stage of drug development.
Cryogenic Cold Solutions are Enhancing Vaccine Efficacy & Yields
April 2nd 2021Paper examines how cryogenic cold-temperature solutions are gaining favor versus traditional mechanical refrigeration methods in the manufacturing, storage, and distribution of vaccines due to their enhanced efficacy, stability and yield.
Superior Monoclonality Assurance for a Successful IND
March 23rd 2021Used by leading pharma companies and CDMOs, the Beacon system offers an integrated end-to-end automated workflow for mammalian cell line development. Clones can be selectively enriched for unique phenotypes and multiple assays can be used to rapidly measure productivity of different antibody molecules.
Seasonal Vaccine Manufacturing
March 17th 2021The seasonal influenza vaccine market is projected to reach more than $4 Billion USD by the end of 2022. It is a safe assumption that as demand for seasonal influenza vaccines increases, so too with the demand for contract manufacturing organizations (CMOs) to support.
Cryogenic Solutions for Constant Temperature Control of Vaccines V2
March 10th 2021Paper examines how cryogenic cold-temperature solutions are gaining favor versus traditional mechanical refrigeration methods in the manufacturing, storage, and distribution of vaccines due to their enhanced efficacy, stability and yield.